Literature DB >> 26804239

Chromogranin A and other enteroendocrine markers in inflammatory bowel disease.

Sara Massironi1, Alessandra Zilli2, Federica Cavalcoli3, Dario Conte4, Maddalena Peracchi5.   

Abstract

Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chromogranin A; Crohn's disease; Enteroendocrine cell; Inflammatory bowel disease; Ulcerative colitis

Mesh：

Substances：

Year:  2016        PMID： 26804239     DOI： 10.1016/j.npep.2016.01.002

Source DB:  PubMed          Journal:  Neuropeptides        ISSN： 0143-4179            Impact factor:   3.286


  10 in total

Review 1.  IBS and IBD - separate entities or on a spectrum?

Authors:  Robin Spiller; Giles Major
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-26       Impact factor: 46.802

2.  Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.

Authors:  Somer Matar; Anna Malczewska; Kjell Oberg; Lisa Bodei; Harry Aslanian; Anna Lewczuk-Myślicka; Pier Luigi Filosso; Alejandro L Suarez; Agnieszka Kolasińska-Ćwikła; Matteo Roffinella; Beata Kos-Kudła; Jarosław B Ćwikła; Ignat A Drozdov; Mark Kidd; Irvin M Modlin
Journal:  Neuroendocrinology       Date:  2019-04-16       Impact factor: 4.914

3.  Regulation of Enteroendocrine Cell Networks by the Major Human Gut Symbiont Bacteroides thetaiotaomicron.

Authors:  Amisha Modasia; Aimee Parker; Emily Jones; Regis Stentz; Arlaine Brion; Andrew Goldson; Marianne Defernez; Tom Wileman; L Ashley Blackshaw; Simon R Carding
Journal:  Front Microbiol       Date:  2020-11-06       Impact factor: 5.640

4.  Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.

Authors:  Zeynep Gök Sargın; Nuray Erin; Gokhan Tazegul; Gülsüm Özlem Elpek; Bülent Yıldırım
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

Review 5.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

6.  Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids.

Authors:  Samaneh K Sarvestani; Steven A Signs; Veronique Lefebvre; Stephen Mack; Ying Ni; Andrew Morton; Ernest R Chan; Xiaoxia Li; Paul Fox; Angela Ting; Matthew F Kalady; Michael Cruise; Jean Ashburn; Jennifer Stiene; Wei Lai; David Liska; Shao Xiang; Emina H Huang
Journal:  Oncotarget       Date:  2018-06-19

Review 7.  Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells.

Authors:  Xiong Sun; Yao Huang; Ya-Li Zhang; Dan Qiao; Yan-Cheng Dai
Journal:  World J Gastroenterol       Date:  2020-12-28       Impact factor: 5.742

8.  Interdependence between Chromogranin-A, Alternatively Activated Macrophages, Tight Junction Proteins and the Epithelial Functions. A Human and In-Vivo/In-Vitro Descriptive Study.

Authors:  Nour Eissa; Hayam Hussein; Diane M Tshikudi; Geoffrey N Hendy; Charles N Bernstein; Jean-Eric Ghia
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

9.  Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions.

Authors:  Kunal Kapoor; Nour Eissa; Diane Tshikudi; Charles N Bernstein; Jean-Eric Ghia
Journal:  World J Gastroenterol       Date:  2021-12-21       Impact factor: 5.742

10.  A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.

Authors:  R Gacesa; A Vich Vila; V Collij; Z Mujagic; A Kurilshikov; M D Voskuil; E A M Festen; C Wijmenga; D M A E Jonkers; G Dijkstra; J Fu; A Zhernakova; F Imhann; R K Weersma
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.